Furthermore, CARD9 deletion in mice with metabolic disorders and obesity improved glucose intolerance, decreased cardiac fibrosis and cardiac dysfunction, reduced cardiac macrophage infiltration into the heart, lowered proinflammatory cytokine production, and attenuated MAPK activity 6,12,13. This evidence concerns the gene CARD9 and obesity disorder.